Massivemarkets

STLN

Starling Oncology, Inc. Common Stock

Nasdaq · usd

$3.20-0.20 (-5.88%)
As of 4:27:18 PM EST on Nov 18, 2026 · 15-minute delayed

Starling Oncology, Inc. Common Stock (STLN) trades at $3.20 (-5.88%) as of 4:27:18 PM EST on Nov 18, 2026, -51.73% over the past month. Market cap is $346.77M, with 5.4 days to cover in short interest.

Stock performance

How Starling Oncology, Inc. Common Stock (STLN) stock has performed from one day to one year, with its 52-week range.

-5.88%
-$0.20 over 1D
$3.16$3.24$3.32$3.399:25 AM11:05 AM12:45 PM2:25 PM4:25 PM$3.20
1D
-5.88%
1W
-23.81%
1M
-51.73%
YTD
-38.10%
1Y
-38.10%
52-wk range
$3.13 – $7.13

Key statistics

Today's trading snapshot for STLN: day range, open, previous close, volume and market cap.

Day range
$3.13 – $3.46
Open
$3.38
Prev close
$3.40
Volume
4.67M
Market cap
$346.77M
Shares out
101.99M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Starling Oncology, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
0.56
P/B
-9.28
P/FCF
18.42
ROE
92.2%
ROA
-18.4%
Debt/Equity
-2.08
Div yield
0.00%

As of Nov 17, 2026

8-K filings

Material corporate events Starling Oncology, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Investor presentationNov 12, 2026

    Starling Oncology, Inc. (the "Company") has prepared an investor presentation (the "Investor Presentation") to use in meetings with investors. A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

  • On November 5, 2026, Starling Oncology, Inc. (the "Company") issued a press release announcing its financial results for the three months ended September 30, 2026 and certain other financial information.

  • Director departureSep 2, 2026

    On September 1, 2026, Brad Hively notified Starling Oncology, Inc. (the "Company") of his decision to not stand for re-election to the Board of the Directors of the Company (the "Board") at its 2027 annual meeting of stockholders (the "Annual Meeting"). Mr. Hively is expected to continue to serve as a director of the Company until the Annual Meeting, but effective immediately, will no longer serve as Vice Chairman of the Board or as a member of the Compliance Committee or any other committees of the Board.

  • Credit facilityAug 21, 2026

    On August 20, 2026, Starling Oncology Management, Limited Liability Company entered into a Credit Agreement (the 'Revolving Loan Agreement') among SOM, LLC and Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL, as lender. The Revolving Loan Agreement provides access to a revolving line of credit facility in the aggregate principal amount of up to $25 million (the 'Revolving Loan Commitment').

STLN short interest

How heavily STLN is shorted: shares short, days to cover and average daily volume.

Days to cover
5.4
Short interest
6.84M
Avg volume
1.26M

As of · reported to FINRA twice monthly.

STLN news

The latest news and headlines about Starling Oncology, Inc. Common Stock (STLN).

Frequently asked questions

What is the Starling Oncology, Inc. Common Stock (STLN) stock price today?

Starling Oncology, Inc. Common Stock (STLN) is trading at $3.20 (-5.88% on the day) as of 4:27:18 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Starling Oncology, Inc. Common Stock?

Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

What is the short interest in STLN?

As of Oct 30, 2026, STLN has 6.84M shares short and 5.4 days to cover.

What exchange is STLN listed on?

Starling Oncology, Inc. Common Stock (STLN) trades on Nasdaq in USD, in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry.

Build with AI

Build an analysis of STLN with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a STLN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.